A very large fraction of the research aimed at the production of interventions to slow aging involves some form of screening small molecule compounds for potential effects. There are huge stock libraries of these things, and many well established approaches to carrying out such screening processes. While new ventures are using machine learning to try to make this process far more efficient than is presently the case, after the fashion of In Silico Medicine, I’d say that the future will be a matter of gene therapy making small molecules obsolete. Gene therapy offers the possibility of precise alteration of the gene expression of a rationally chosen target, rather than the uncertainty, serendipity, and off-target effects inherent in small molecule development. Still, much of the community, particularly
from
https://healthnews010.wordpress.com/2019/04/03/small-molecule-screening-for-longevity-effects-in-nematode-worms/
from https://karlfletcher.blogspot.com/2019/04/small-molecule-screening-for-longevity.html
from
https://karlfletcher1.tumblr.com/post/183907344718
No comments:
Post a Comment